West Pharma Fully Operational After Cyberattack, No Material Financial Impact Expected
WST sits 50% above its 52-week low of $203.74.
Summary
West Pharmaceutical Services announced it is fully operational following a recent cybersecurity attack and does not expect a material financial impact on its 2026 guidance.
Key Events · Legal and Risk Events · WST
-
Cybersecurity Incident Remediation Progress
Core enterprise systems have been restored, and critical manufacturing, receiving, and shipping processes are fully restarted at all sites following the May 7, 2026 cybersecurity attack.
-
Full Operational Status Achieved
The company is now fully operational across its manufacturing, supply chain, and commercial sites globally, with no unauthorized activity observed since May 5, 2026.
-
No Material Financial Impact on Guidance
Based on the ongoing investigation, the company believes the incident is not reasonably likely to have a material impact on its 2026 second-quarter and full-year financial guidance.
Analysis · WST · Industrial Applications And Services
This amended filing provides a crucial update on the recent material cybersecurity incident, indicating that West Pharmaceutical Services has successfully restored core systems and is fully operational. Most importantly, the company now believes the incident will not materially impact its 2026 second-quarter and full-year financial guidance, significantly mitigating concerns raised by the initial disclosure on May 11, 2026.
At the time of this filing, WST was trading at $305.50 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $21.6B. The 52-week trading range was $203.74 to $330.88. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.